Manifest-2, A Global, Phase 3, Randomized, Double-Blind, Active-Control Study Of Pelabresib (Cpi-0610) And Ruxolitinib Vs Placebo And Ruxolitinib In Jak Inhibitor-Naive Myelofibrosis Patients
Pelabresib;Ruxolitinib;Ruxolitinib
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Manifest-2, A Global, Phase 3, Randomized, Double-Blind, Active-Control Study Of Pelabresib (Cpi-0610) And Ruxolitinib Vs Placebo And Ruxolitinib In Jak Inhibitor-Naive Myelofibrosis Patients ### Output: Pelabresib;Ruxolitinib;Ruxolitinib